The “Africa Beta-Glucan Market – Growth, Trends and Forecasts (2017 – 2022)” report has been added to Research and Markets’ offering.
The Africa Beta-Glucan Market accounted for USD 12.82 million in 2016 and is expected to reach USD 19.75 million by 2022, with a CAGR of 7.4%.
Factors driving the beta-glucan industry are the increasing consumption of nutraceuticals and functional food, its usage as immunomodulator (immunomodulators are chemical agents that modify the immune response or the functioning of the immune system) and increased usage as fat substitutes. Another major market trend is the consumers shifting to processed foods, to proactively strengthen their immune system. A large part of the working class in these regions belongs to the age group of 18 to 50 years, which includes men and women. The consumption level of beta-glucan is very high, which helps to keep people healthy and proactive.
Moreover, there has been an abundant opportunity for growth in these regions due to the emerging economies and the governments’ initiatives. The demand for beta-glucan products has increased due to a change in the eating patterns and rise in consumption of processed foods, coupled with high disposable incomes in the South African countries. Beta-glucan is a natural immune booster, intended to protect against all interruptions that may bring about damage to the body.
– Associated British Foods Plc
– Tate & Lyle Oat Ingredients
– Lesaffre Human Care
– Biothera Inc.
– Royal DSM N.V.
– AIT Ingredients (The Soufflet Group)
– Bio Springer
– Chr. Hansen
– Ozone Company
Key Topics Covered:
2. Research Approach and Methodology
3. Market Overview
4. Market Segmentation
5. Competitive Landscape
6. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/2wfhw6/africa